532 related articles for article (PubMed ID: 32085487)
1. Marine Omega-3 (N-3) Fatty Acids for Cardiovascular Health: An Update for 2020.
Innes JK; Calder PC
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085487
[TBL] [Abstract][Full Text] [Related]
2. Pros and Cons of Long-Chain Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Health.
Djuricic I; Calder PC
Annu Rev Pharmacol Toxicol; 2023 Jan; 63():383-406. PubMed ID: 36662586
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review.
Balk EM; Adams GP; Langberg V; Halladay C; Chung M; Lin L; Robertson S; Yip A; Steele D; Smith BT; Lau J; Lichtenstein AH; Trikalinos TA
Evid Rep Technol Assess (Full Rep); 2016 Aug; (223):1-1252. PubMed ID: 30307737
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acids from fish oils and cardiovascular disease.
Holub DJ; Holub BJ
Mol Cell Biochem; 2004 Aug; 263(1-2):217-25. PubMed ID: 15524182
[TBL] [Abstract][Full Text] [Related]
5. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
6. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G
Eur J Prev Cardiol; 2024 Jun; ():. PubMed ID: 38869144
[TBL] [Abstract][Full Text] [Related]
7. Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis and Meta-Regression of Interventional Trials.
Bernasconi AA; Wiest MM; Lavie CJ; Milani RV; Laukkanen JA
Mayo Clin Proc; 2021 Feb; 96(2):304-313. PubMed ID: 32951855
[TBL] [Abstract][Full Text] [Related]
8. Fish and Omega-3 Fatty Acids: Sex and Racial Differences in Cardiovascular Outcomes and Cognitive Function.
Welty FK; Daher R; Garelnabi M
Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):89-107. PubMed ID: 37916414
[TBL] [Abstract][Full Text] [Related]
9. The ratio of eicosapentaenoic acid to docosahexaenoic acid as a modulator for the cardio-metabolic effects of omega-3 supplements: A meta-regression of randomized clinical trials.
AbuMweis S; Abu Omran D; Al-Shami I; Jew S
Complement Ther Med; 2021 Mar; 57():102662. PubMed ID: 33418065
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 fatty acids in coronary heart disease: Recent updates and future perspectives.
Ajith TA; Jayakumar TG
Clin Exp Pharmacol Physiol; 2019 Jan; 46(1):11-18. PubMed ID: 30230571
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acids and cardiovascular disease: new developments and applications.
Harris WS; Dayspring TD; Moran TJ
Postgrad Med; 2013 Nov; 125(6):100-13. PubMed ID: 24200766
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 fatty acids in cardiovascular disease--an uphill battle.
von Schacky C
Prostaglandins Leukot Essent Fatty Acids; 2015 Jan; 92():41-7. PubMed ID: 24935800
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acids from fish oils and cardiovascular disease.
Holub DJ; Holub BJ
Mol Cell Biochem; 2004 Aug; 263(1):217-25. PubMed ID: 27520680
[TBL] [Abstract][Full Text] [Related]
14. Intake of total omega-3 fatty acids, eicosapentaenoic acid and docosahexaenoic acid and risk of coronary heart disease in the Spanish EPIC cohort study.
Amiano P; Machón M; Dorronsoro M; Chirlaque MD; Barricarte A; Sánchez MJ; Navarro C; Huerta JM; Molina-Montes E; Sánchez-Cantalejo E; Urtizberea M; Arriola L; Larrañaga N; Ardanaz E; Quirós JR; Moreno-Iribas C; González CA
Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):321-7. PubMed ID: 24360762
[TBL] [Abstract][Full Text] [Related]
15. Fish, Fish Oils and Cardioprotection: Promise or Fish Tale?
Goel A; Pothineni NV; Singhal M; Paydak H; Saldeen T; Mehta JL
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30469489
[TBL] [Abstract][Full Text] [Related]
16. A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk.
Alexander DD; Miller PE; Van Elswyk ME; Kuratko CN; Bylsma LC
Mayo Clin Proc; 2017 Jan; 92(1):15-29. PubMed ID: 28062061
[TBL] [Abstract][Full Text] [Related]
17. Plant compared with marine n-3 fatty acid effects on cardiovascular risk factors and outcomes: what is the verdict?
Sanders TA
Am J Clin Nutr; 2014 Jul; 100 Suppl 1():453S-8S. PubMed ID: 24898234
[TBL] [Abstract][Full Text] [Related]
18. Prevention of Endothelial Dysfunction and Cardiovascular Disease by n-3 Fatty Acids-Inhibiting Action on Oxidative Stress and Inflammation.
Yamagata K
Curr Pharm Des; 2020; 26(30):3652-3666. PubMed ID: 32242776
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 fatty acids and cardiovascular disease.
von Schacky C
Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):129-35. PubMed ID: 17284999
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials.
Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL
Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
